Axonica Labs
Axonica Labs
Stealth ModeAxonica Labs is developing AI-powered solutions for brain health, focusing on early detection and personalized interventions for neurological conditions.
About
What does Axonica Labs do?
Axonica Labs is a startup dedicated to advancing brain health through artificial intelligence. They are developing innovative solutions for the early detection, monitoring, and personalized management of neurological conditions, aiming to improve patient outcomes and quality of life.
Where is Axonica Labs headquartered?
Axonica Labs is headquartered in נתניה, Israel.
When was Axonica Labs founded?
Axonica Labs was founded in 2026.
What industry does Axonica Labs operate in?
Axonica Labs operates in HealthTech, MedTech, Neurotech, Brain-Computer Interface, Non-Invasive BCI, AI Drug Discovery.
What is Axonica Labs's current status?
Axonica Labs's current operating status is: Inactive.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.